Besides, EMT in tumor cells such as colon cancer cells, skin cancer cells, and breast cancer cells as well can be reversed via lowering the expression of TβR. Targeted therapy that inhibits the expression of TβRI might have the ability to block EMT by promoting the formation of epithelial phenotype and reducing mesenchymal differentiation. This evidence concerns the gene TGFBR1 and colonic neoplasm.